-
Oncogenesis: Rae Gongto extract helps treat pancreatic cancer
Time of Update: 2020-12-26
December 18, 2020 /--- City of Hope affiliate Translational Genomics Research Institute (TGen) researchers conducted a preclinical study results show that Lei Gongto, a Chinese herbal medicine used in
-
The underlying cause of targeted complement disease! FDA grants Novartic oral strong selective factor B inhibitor iptacopan breakthrough drug eligibility!
Time of Update: 2020-12-26
based on positive mid-term data from the disease prevalence and Phase 2 studies, iptacopan was also awarded treatment for C3G and PNH by the FDA and ODD by the EMA.
-
The first Esophedritis (EoE) drug! Takeda TAK-721 (Budined oral suspension) is under FDA priority review!
Time of Update: 2020-12-26
December 16, 2020 // -- Takeda recently announced that the U.S. Food and Drug Administration (FDA) has accepted TAK-721's new drug application (NDA) and granted priority review.
-
Sword refers to Roche Merro! Amgen Lytoxi monobial-like drug Riamni is approved by the FDA!
Time of Update: 2020-12-26
December 18, 2020 // -- Amgen recently announced that the U.S. Food and Drug Administration (FDA) has approved Ribni (rituximab-arrx, rituximab-rituximab), a Roche ace biologic agent Rituxan (Chinese Product Name: Meroma, generic name: rituximab, rituximab, rituximab biosynthetic drug for the treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), granuloma with polyvascularitis (GPA), microscopic multi-hemanitis (MPA) adult patients.
-
Sci Rep: Scientists have developed new algorithms that could prevent misrecognization of cancer cells!
Time of Update: 2020-12-26
December 17, 2020 // -- In a recent study published in the international journal Scientific Reports entitled "Towards image-base cell cell lines using deep neural networks", scientists from institutio
-
Eur Heart J: Immuno-checkpoint inhibitor therapy can induce heart disease
Time of Update: 2020-12-25
(Photo: www.pixabay.com) Maria D'Souza, M.D., from Herlev-Gentofte Hospital, University of Copenhagen, Denmark, and colleagues studied the risk of heart events or cardiovascular death in patients with continuous lung cancer or malignant melanoma in Denmark between 2011 and 2017.
-
The Lancet Microbe: How to Prevent and Control New Outbreaks
Time of Update: 2020-12-25
"Given the limitations of current models for disease prevention, our article focuses on coordinated and broad early detection strategies to stop new disease outbreaks before they can become a global pandemic." " (Bioon.com) Source: Researchers propose process to detect and containemerging diseases Original source: Kristian M Forbes et al, Towards a cosy strategy for intercepting human diseases in Africa, The Lancet Microbe (2020).
-
AJPHCP: ACE2 protein protects COVID-19 severe disease response
Time of Update: 2020-12-25
"Our study focused on how gender differences in COVID-19 are associated with ACE2," said Gavin Oudit, professor of medicine at the Canadian College of Medicine and Dentistry and chairman of heart failure research and director of cardast function.
-
AJT: Individualized therapy relieves immune rejection after lung transplantation
Time of Update: 2020-12-25
"We realized that the way to stop this phenomenon was by discovering the cause of this scar formation and how it developed to provide patients with novel and personalized therapies." (Photo Source: Www.pixabay.com) Lama is the senior author of both papers, which demonstrate a link between antibodies targeting the lungs of the body and a particularly aggressive chronic rejection reaction after lung transplantation, known as restrictive allogeneic transplant syndrome or RAS.
-
Cell: The antibody can prevent severe neo-coronary pneumonia
Time of Update: 2020-12-25
now, in a new study, researchers from the Lagan Institute in the United States and Massachusetts General Hospital have found that the effectiveness of the meso-antibodies produced in patients with severe or fatal diseases is significantly reduced compared to those with lighter infections.
-
Here are five things you need to know about the safety of the COVID-19 mRNA vaccine!
Time of Update: 2020-12-25
in clinical trials, this new mRNA vaccine has at least 94% effect in preventing people from developing COVID-19, but what about the safety of this new technology?
-
A quick overview of the top research reports on the MedicalXpress website in 2020!
Time of Update: 2020-12-25
addition, scientists from Northwestern University in the United States have found evidence of damage to the placenta of COVID-19-positive pregnant women by studying another way the SARS-CoV2 virus harms humans.
-
Scientists hope to develop a new cancer immunotherapy for multiple solid tumors!
Time of Update: 2020-12-25
20, 2020 /PRY/ -- Scientists from Purdue University and others have developed a new type of cancer immunotherapy that could help treat multiple solid tumors, according to a recent study published in t
-
Clin Infect Dis: The greatest risk factor for death from COVID-19 infection
Time of Update: 2020-12-25
study, conducted by researchers at the University of Maryland School of Medicine (UMSOM), showed that hospitalized COVID-19 patients were at higher risk of death if they were male, obese or had complications of diabetes or high blood pressure.
-
JCI Insight: Zika virus infection affects eye development before birth
Time of Update: 2020-12-25
(Photo: www.pixabay.com) A new study by Glenn Yiu, an associate professor at the Davis Eye Center at the University of California, Davis, and Koen Van Rompay of the National Primate Research Center in California found that Zika infection in early pregnancy can affect fetal retinal development and lead to congenital eye abnormalities.
-
Interpretation! How can scientists improve survival rates in cervical cancer patients by targeting "zombie" cells that act on aging?
Time of Update: 2020-12-24
that cervical cancer patients' response to therapy is closely related to survival and levels of 10 proteins in the blood, which are associated with the state of aging cells.
-
Ann Rheum Dis: A meta-analysis of 208,370 East Asians identified 113 susceptible gene constellations for systemic lupus erythematosus
Time of Update: 2020-12-24
to discover new SLE gene constellations and causal variants, the study conducted the largest genome-wide meta-analysis to date in the East Asian population.
study identified 113 susceptible gene constellations for systemic lupus erythematosus and showed that large-scale genome-wide meta-analysis plays an important role in new genetic discoveries.
-
Ann Rheum Dis: Risk of fractures in patients with rheumatoid arthritis who use both glucoticoids and proton pump inhibitors
Time of Update: 2020-12-24
compared to the non-use of these two drugs, both oral GC and PPI are currently associated with a 1.6-fold increased risk of osteoporosis fractures (adjusted HR: 1.60, 95% CI: 1.35-1.89).
when RA patients take both oral GC and PPI, care should be taken to assess their fracture risk.
-
Scientists have successfully used three combination therapies to treat thyroid cancer!
Time of Update: 2020-12-24
December 21, 2020 // -- A recent article published in the international magazine Journal for ImmunoTherapy of Cancer entitled "Combining BRAF resedion with oncolytic herpes simplex virus enhances the immune-mediated anti Scientists from institutions such as the London Cancer Institute have found that combining a gene-targeted drug, a cancer outbreak virus and a drug that removes the immune system's brake pedals could hopefully help fight thyroid cancer, according to a study by BRAF-mutant thyroid cancer.
-
Cell heavy interpretation! Obesity impairs the molecular mechanisms of immune cell function and accelerates tumor growth!
Time of Update: 2020-12-22
Blocks fat-related metabolic reprogramming or significantly reduces tumor volume in mice on a high-fat diet, and since CD8-T cells are the primary weapon for immunotherapy to activate the host body's immune system against cancer, in this study, researchers propose new strategies to improve such therapies.